Joyce A. Boucheron - Concepedia

Author

Joyce A. Boucheron

Research Triangle Park Foundation

Also Known As

J A Boucheron, J. Boucheron, J.A. Boucheron, Joyce A Boucheron, Joyce A. Boucheron, Joyce Boucheron

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)

About

Joyce A. Boucheron is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	708
2	Health Sciences	5	5	306
3	Biochemistry	4	4	141
4	Natural Sciences	2	2	102
5	Allergy	1	1	55

Joyce A. Boucheron

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Vinyl chloride-induced DNA adducts II: Formating and persistence of 7-(2'oxoethyl)guanine and <i>N</i><sup>2</sup> ,3 ethenoguanine in rat tissue DNA N. Fedtke, Joyce A. Boucheron, Vernon E. Walker, Carcinogenesis	1990	107
Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Steven A. Belinsky, Catherine M. White, Joyce A. Boucheron, PubMed Respiratory ToxicologyTobacco Specific CarcinogenNasal Cavity TumorsMedicineLung Dna	1986	105
Relationships between DNA adduct formation and carcinogenesis. James A. Swenberg, Frank C. Richardson, Joyce A. Boucheron, Environmental Health Perspectives Pyrimidine AlkylationEpigenetic ChangePathologyEpigeneticsToxicology	1985	97
<i>N</i>-Phenyl-4-pyrazolo[1,5-<i>b</i>]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy Francis X. Tavares, Joyce A. Boucheron, Scott H. Dickerson, Journal of Medicinal Chemistry Cellular PharmacologySelective InhibitorsPharmaceutical ChemistryInsulin SignalingMolecular Pharmacology	2004	91
High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substances. James A. Swenberg, Frank C. Richardson, Joyce A. Boucheron, Environmental Health Perspectives Low-dose ExtrapolationPathologyDose ResponseCell ProliferationCritical Determinants	1987	84
P2U Agonists Induce Chemotaxis and Actin Polymerization in Human Neutrophils and Differentiated HL60 Cells Margrith W. Verghese, Tracy B. Kneisler, Joyce A. Boucheron Journal of Biological Chemistry	1996	82
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors Andrew J. Peat, Joyce A. Boucheron, Scott H. Dickerson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNovel Pyrazolopyrimidine DerivativesPharmacological AgentPharmacotherapy	2004	67
Molecular dosimetry of O4-ethyldeoxythymidine in rats continuously exposed to diethylnitrosamine. Joyce A. Boucheron, Frank C. Richardson, Paul H. Morgan, PubMed PharmacotherapyOxidative StressDrug ResistanceEnvironmental HealthToxicology	1987	55
Formation of O6-Methyldeoxyguanosine at Specific Sites in a Synthetic Oligonucleotide Designed to Resemble a Known Mutagenic Hotspot Frank C. Richardson, Joyce A. Boucheron, T R Skopek, Journal of Biological Chemistry	1989	52
Novel GSK-3 inhibitors with improved cellular activity Andrew J. Peat, Dulce Garrido, Joyce A. Boucheron, Bioorganic & Medicinal Chemistry Letters MedicineReceptor Tyrosine KinaseCellular PharmacologyNovel Gsk-3 InhibitorsAnti-cancer Agent	2004	52

Page 1